Time to Retire Beta-Blockers in Uncomplicated Hypertension
Time to Retire Beta-Blockers in Uncomplicated HypertensionBeta-blockers were one of the first modern medications used for the treatment of blood pressure. Before 1950, treatment options for hypertension were limited. The alphabet soup of medications -- reserpine, pentaquine, hydralazine, and guanethidine -- were notorious for inducing orthostasis, sedation, constipation, impotence, or blurry vision.
Testosterone Tx Gives Weak Signal for Cardiovascular RiskThere is no compelling evidence that testosterone therapy increases or decreases cardiovascular risk, according to a new position statement from the American Academy of Clinical Endocrinologists (AACE). The statement was issued in response to recent publications that have raised concern that testosterone replacement therapy (TRT) increases cardiovascular risks in men and media reports about the dangers of testosterone therapy.
High Blood Pressure Tied to Greater Risk for T2DElevated blood pressure was associated with an increased risk for diabetes, according to an analysis of the electronic health records (EHRs) and a meta-analysis.
How Express Scripts will manage pricey cholesterol drugsAfter much criticism on the price of 2 new cholesterol-lowering drugs, Praluent and Repatha, Express Scripts said this week it will now include both drugs in its National Preferred Formulary.
Hypertension in an infant girlA previously healthy 8-month-old girl presented to the emergency department with fever and increased work of breathing. She was hospitalized for hypoxia attributed to community-acquired pneumonia, treated with ceftriaxone, and weaned to room air over several days. On the morning of planned discharge, she was noted to have had persistently elevated blood pressures for the past 12 hours.
Mild chronic hypertension in pregnancy: To treat or not to treat?The debate over which approach most benefits mother and baby still rages.
Optic neuropathy diagnosed via hypertension
Optic neuropathy diagnosed via hypertensionAnterior ischemic optic neuropathy (AION) was first described in 1974. It results from non-perfusion of the posterior ciliary blood supply to the optic nerve head.
5 things to know about cholesterol-lowering PCSK9 inhibitorsThis summer, the first two drugs in the new class of cholesterol-lowering medications, known as PCSK9 inhibitors, are expected to be approved by the FDA. If approved, PCSK9 inhibitors will change how chronic conditions are treated.
Managing patients with hypertension: Tips and strategies to improve the care you provide your hypertensive patientsHypertension needs to be managed quickly and carefully for patients to avoid health problems
Hypertension: Key coding considerationsHere are some key coding considerations when working with patients with hypertension and hypertension related symptoms.